Altamira Therapeutics Ltd. Number of Operating Segments
Altamira Therapeutics Ltd. (CYTOF) reported Number of Operating Segments of 100.00% for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-31.
Discontinued › Notes
us-gaap:NumberOfOperatingSegments · last filed 2021-03-31
| Period end | Number of Operating Segments 12 month |
|---|---|
| 2020-12-31 | 100.00% 20-F · filed 2021-03-31 |